TLSI Q3 2023 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+32.4% YoY

Gross Profit

$5M88.7% margin

Operating Income

-$19M-358.5% margin

Net Income

-$1M-27.4% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+12.6%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$34M

Total Liabilities

$25M

Stockholders' Equity

$8M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+32.4%
Gross Profit	$5M	$3M	+42.9%
Operating Income	-$19M	-$8M	-129.5%
Net Income	-$1M	-$8M	+82.4%